Stefani Wolff

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
South San Francisco, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Ryan Murr, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Stefani Wolff

Form 4 holding EVP and COO

Nurix Therapeutics, Inc.

Security class
Restricted Stock Units
Shares / value
10,582
Estimated value
$84,552
Report date
30 Apr 2023
Price
$7.99
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding EVP and COO

Nurix Therapeutics, Inc.

Security class
Common Stock
Shares / value
6,113
Estimated value
$61,149
Report date
01 May 2023
Price
$10.00
Ownership
Direct
Form 4 holding Director

Rain Oncology Inc.

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
26 Jan 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Stefani Wolff

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .